Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen

Using Panitumumab with metronomic Capecitabine is considered an accepted maintenance regimen in wild type <i>Ras</i> metastatic colorectal cancer regardless of the primary site.

Authors

Institutions

Publication Details

Journal
Oncotarget
Published
2025-02-12
DOI
https://doi.org/10.18632/oncotarget.28687
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen

Aiat Morsy, Doaa A Gamal, Mervat Omar
Oncotarget
Colorectal Cancer Treatments and Studies
article

Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen

Aiat Morsy, Doaa A Gamal, Mervat Omar
article en

Abstract

Using Panitumumab with metronomic Capecitabine is considered an accepted maintenance regimen in wild type <i>Ras</i> metastatic colorectal cancer regardless of the primary site.

OncotargetVol. 16(1)
Assiut University (EG)
Zero hunger
Openalex Percentile: Top 96%
Colorectal Cancer Treatments and Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Could Panitumumab with very low dose Capecitabine be an option as a maintenance regimen — Aiat Morsy, Doaa A Gamal, et al. · Oncotarget (2025) | TGRS Research Map | TGRS